Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -24.64%448.68M | ---- | 65.91%595.43M | ---- | -51.98%358.88M | ---- | 1.85%747.28M | ---- | 50.42%733.68M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -16.12%-82.78M | ---- | -24.30%-71.29M | ---- | -20.70%-57.36M | ---- | -8.99%-47.52M | ---- | 0.97%-43.6M |
| Attributable subsidiary (profit) loss | ---- | 273.83%18.97M | ---- | -111.02%-10.91M | ---- | 1,042.81%99.07M | ---- | 347.97%8.67M | ---- | -115.13%-3.5M |
| Impairment and provisions: | ---- | 128.49%4.57M | ---- | -106.05%-16.02M | ---- | 499.00%264.93M | ---- | 39.22%44.23M | ---- | 2,195.45%31.77M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | --11.79M | ---- | ---- | ---- | 12.51%31.1M | ---- | --27.64M |
| -Impairment of trade receivables (reversal) | ---- | 159.41%12.45M | ---- | -176.67%-20.96M | ---- | --27.33M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -15.03%-7.88M | ---- | -102.88%-6.85M | ---- | 1,709.58%237.6M | ---- | 218.15%13.13M | ---- | 223.71%4.13M |
| Revaluation surplus: | ---- | -40.11%7.21M | ---- | 104.99%12.04M | ---- | -4,292.50%-241.53M | ---- | 42.07%5.76M | ---- | 3,720.54%4.06M |
| -Fair value of investment properties (increase) | ---- | 364.41%2.34M | ---- | 239.34%503K | ---- | -106.27%-361K | ---- | 42.07%5.76M | ---- | 3,720.54%4.06M |
| -Other fair value changes | ---- | -57.75%4.88M | ---- | 104.79%11.54M | ---- | ---241.17M | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | -58.54%5.3M | ---- | 3.65%12.77M | ---- | -64.59%12.32M | ---- | 48.52%34.8M | ---- | 127.39%23.43M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -58.54%5.3M | ---- | 3.65%12.77M | ---- | -64.59%12.32M | ---- | 48.52%34.8M | ---- | 127.39%23.43M |
| Depreciation and amortization: | ---- | 9.61%459.31M | ---- | 7.26%419.06M | ---- | 12.42%390.69M | ---- | 12.58%347.52M | ---- | 5,477.86%308.68M |
| -Depreciation | ---- | 33.87%6.72M | ---- | -93.31%5.02M | ---- | -5.47%74.97M | ---- | -0.12%79.31M | ---- | 1,334.86%79.41M |
| -Other depreciation and amortization | ---- | 0.00%17.3M | ---- | 114.79%17.3M | ---- | --8.06M | ---- | ---- | ---- | ---- |
| Financial expense | ---- | -13.77%151.41M | ---- | 3.68%175.58M | ---- | 13.49%169.34M | ---- | -7.31%149.22M | ---- | -20.48%160.99M |
| Operating profit before the change of operating capital | ---- | -9.31%1.01B | ---- | 12.07%1.12B | ---- | -22.76%996.35M | ---- | 6.12%1.29B | ---- | 18.68%1.22B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -30.05%162.38M | ---- | 23.69%232.12M | ---- | 141.73%187.67M | ---- | -542.97%-449.7M | ---- | -136.67%-69.94M |
| Accounts receivable (increase)decrease | ---- | -134.77%-70.99M | ---- | 189.08%204.19M | ---- | -358.35%-229.22M | ---- | -0.60%88.72M | ---- | -69.33%89.26M |
| Accounts payable increase (decrease) | ---- | -568.37%-335.8M | ---- | 65.11%-50.24M | ---- | -134.89%-144.02M | ---- | 393.14%412.79M | ---- | -135.01%-140.82M |
| prepayments (increase)decrease | ---- | 366.69%63.75M | ---- | 124.78%13.66M | ---- | -19.86%-55.11M | ---- | -232.14%-45.98M | ---- | -40.29%34.8M |
| Special items for working capital changes | ---- | 73.76%-3.31M | ---- | 76.57%-12.62M | ---- | -26,911.44%-53.89M | ---- | -91.20%201K | ---- | -96.30%2.28M |
| Cash from business operations | -21.63%245.05M | -44.89%828.68M | -56.06%312.68M | 114.28%1.5B | 92.17%711.67M | -45.85%701.78M | -53.66%370.33M | 14.58%1.3B | 101.93%799.09M | -27.77%1.13B |
| Other taxs | 14.28%-63.09M | -50.92%-148.14M | -190.71%-73.59M | 36.83%-98.16M | 75.64%-25.32M | 32.13%-155.38M | 5.71%-103.92M | -17.82%-228.95M | -12.49%-110.21M | -108.48%-194.32M |
| Net cash from operations | -23.89%181.97M | -51.58%680.54M | -65.17%239.09M | 157.25%1.41B | 157.63%686.36M | -48.79%546.4M | -61.33%266.41M | 13.91%1.07B | 131.37%688.88M | -36.40%936.77M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -43.23%19.07M | 37.56%54.75M | 66.60%33.59M | 33.25%39.8M | 76.53%20.16M | 21.30%29.87M | -18.42%11.42M | -19.86%24.62M | -6.99%14M | 3.58%30.73M |
| Loan receivable (increase) decrease | 190.92%74.42M | -239.67%-81.72M | 893.70%25.58M | 135.16%58.51M | 87.58%-3.22M | 52.24%-166.4M | 77.18%-25.95M | 4.22%-348.43M | -1,413.16%-113.73M | 3.29%-363.79M |
| Decrease in deposits (increase) | 30.48%79.87M | -192.25%-270.95M | -37.44%61.21M | 200.74%293.72M | 135.47%97.85M | -90.42%-291.57M | 6.39%-275.82M | -160.76%-153.12M | -4.80%-294.65M | 11,235.45%251.99M |
| Sale of fixed assets | 13.84%11.48M | -45.76%14M | -36.96%10.09M | 154.18%25.82M | 41.07%16M | -54.22%10.16M | 112.18%11.34M | 69.76%22.19M | 557.44%5.35M | 52.37%13.07M |
| Purchase of fixed assets | -72.97%-429.87M | 3.64%-493.54M | -9.42%-248.52M | 22.18%-512.18M | 32.65%-227.12M | 31.06%-658.19M | 29.41%-337.22M | -46.83%-954.68M | -32.29%-477.69M | 6.89%-650.18M |
| Purchase of intangible assets | ---2.02M | -1,114.00%-6.68M | ---- | ---550K | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---28.17M | ---- | ---- | ---- | ---- | ---- | ---- | ---18.69M | ---- | ---- |
| Cash on investment | ---- | -334.90%-100.49M | ---- | 59.11%-23.11M | ---- | 63.43%-56.51M | -945.09%-36.94M | -507.16%-154.54M | 537.10%4.37M | 33.55%-25.45M |
| Other items in the investment business | -53.33%3.5M | ---- | 1,685.71%7.5M | ---- | 112.00%420K | ---- | ---3.5M | -48.52%195.85M | ---- | 26.27%380.42M |
| Net cash from investment operations | -145.80%-271.73M | -649.65%-884.63M | -15.25%-110.55M | 89.58%-118.01M | 85.39%-95.92M | 18.33%-1.13B | 23.85%-656.67M | -281.81%-1.39B | -41.90%-862.36M | 52.89%-363.22M |
| Net cash before financing | -169.83%-89.76M | -115.85%-204.09M | -78.23%128.54M | 319.63%1.29B | 251.29%590.44M | -83.34%-586.25M | -124.97%-390.26M | -155.75%-319.76M | 44.04%-173.48M | -18.27%573.55M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 30.54%2.31B | -3.63%2.94B | 1.12%1.77B | -21.51%3.05B | -18.78%1.75B | 16.85%3.89B | 18.26%2.16B | -9.80%3.33B | -22.30%1.82B | 12.64%3.69B |
| Refund | -7.02%-1.99B | -7.42%-3.24B | 1.63%-1.86B | 11.33%-3.02B | 7.30%-1.89B | -20.35%-3.41B | -12.97%-2.04B | 20.33%-2.83B | -3.74%-1.81B | -2.07%-3.55B |
| Issuing shares | ---- | ---- | ---- | --365.31M | ---- | ---- | ---- | --107.47M | --107.47M | ---- |
| Interest paid - financing | 19.97%-77.29M | 13.40%-173.61M | 9.44%-96.58M | 1.25%-200.48M | 0.59%-106.66M | -4.86%-203.02M | -12.94%-107.29M | 2.40%-193.61M | -0.60%-94.99M | 16.36%-198.37M |
| Dividends paid - financing | -43,709.52%-9.2M | ---- | 84.44%-21K | 99.88%-135K | 99.85%-135K | -657,170.59%-111.74M | ---92.62M | ---17K | ---- | ---- |
| Absorb investment income | ---- | ---- | -63.16%21K | -87.90%56K | -47.71%57K | --463K | --109K | ---- | ---- | 123.79%121.13M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | -8,944.11%-278.02M | ---103.84M | 97.00%-3.07M | ---- | -2.30%-102.3M | ---2.3M | 0.00%-100M |
| Other items of the financing business | -28.50%-196.16M | 158.09%261.74M | 23.12%-152.65M | -201.17%-450.58M | -151.61%-198.55M | 95.76%445.38M | -28.31%384.73M | 135.62%227.52M | 579.83%536.69M | -5,035.86%-638.75M |
| Net cash from financing operations | 109.23%31.82M | 59.15%-228.69M | 39.41%-344.79M | -192.14%-559.81M | -291.45%-569.02M | 13.33%607.55M | -47.03%297.21M | 178.88%536.07M | 41.53%561.13M | -34.13%-679.59M |
| Effect of rate | 200.45%7.98M | 46.53%-3.77M | 256.38%2.66M | -2,393.49%-7.04M | --745K | --307K | ---- | ---- | ---- | ---- |
| Net Cash | 73.21%-57.94M | -159.46%-432.77M | -1,109.90%-216.25M | 3,316.81%727.78M | 123.01%21.41M | -90.15%21.3M | -124.00%-93.05M | 303.97%216.3M | 348.20%387.65M | -154.37%-106.05M |
| Begining period cash | -27.77%1.14B | 84.68%1.57B | 84.68%1.57B | 2.60%851.18M | 2.60%851.18M | 35.27%829.57M | 35.27%829.57M | -14.74%613.27M | -14.74%613.27M | 37.21%719.31M |
| Cash at the end | -20.09%1.09B | -27.77%1.14B | 55.53%1.36B | 84.68%1.57B | 18.58%873.34M | 2.60%851.18M | -26.42%736.53M | 35.27%829.57M | 24.21%1B | -14.74%613.27M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --613.27M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --613.27M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants | -- | Grant Thornton (Hong Kong) Certified Public Accountants | -- | Grant Thornton (Hong Kong) Certified Public Accountants | -- | Grant Thornton (Hong Kong) Certified Public Accountants | -- | Grant Thornton (Hong Kong) Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.